Proteomic profiling of HBV infected liver biopsies with different fibrotic stages        
Yazarlar (11)
Seyma Katrinli
İstanbul Teknik Üniversitesi, Türkiye
Kamil Ozdil
Umraniye Teaching And Research Hospital, Türkiye
Prof. Dr. Abdurahman ŞAHİN Umraniye Teaching And Research Hospital, Türkiye
Oguzhan Ozturk
Umraniye Teaching And Research Hospital, Türkiye
Gozde Kir
Umraniye Teaching And Research Hospital, Türkiye
Ahmet Tarik Baykal
Acıbadem Mehmet Ali Aydınlar Üniversitesi, Türkiye
Emel Akgun
Acıbadem Mehmet Ali Aydınlar Üniversitesi, Türkiye
Omer Sinan Sarac
İstanbul Teknik Üniversitesi, Türkiye
Mehmet Sokmen
Umraniye Teaching And Research Hospital, Türkiye
H. Levent Doğanay
Umraniye Teaching And Research Hospital, Türkiye
Gizem Dinler Doğanay
İstanbul Teknik Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Proteome Science
Dergi ISSN 1477-5956 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 04-2017
Cilt No 15
Sayı 1
Sayfalar 1 / 11
DOI Numarası 10.1186/s12953-017-0114-4
Makale Linki http://proteomesci.biomedcentral.com/articles/10.1186/s12953-017-0114-4
Özet
Background: Hepatitis B virus (HBV) is a global health problem, and infected patients if left untreated may develop cirrhosis and eventually hepatocellular carcinoma. This study aims to enlighten pathways associated with HBV related liver fibrosis for delineation of potential new therapeutic targets and biomarkers. Methods: Tissue samples from 47 HBV infected patients with different fibrotic stages (F1 to F6) were enrolled for 2D-DIGE proteomic screening. Differentially expressed proteins were identified by mass spectrometry and verified by western blotting. Functional proteomic associations were analyzed by EnrichNet application. Results: Fibrotic stage variations were observed for apolipoprotein A1 (APOA1), pyruvate kinase PKM (KPYM), glyceraldehyde 3-phospahate dehydrogenase (GAPDH), glutamate dehydrogenase (DHE3), aldehyde dehydrogenase (ALDH2), alcohol dehydrogenase (ALDH1A1), transferrin (TRFE), peroxiredoxin 3 (PRDX3), phenazine biosynthesis-like domain-containing protein (PBLD), immuglobulin kappa chain C region (IGKC), annexin A4 (ANXA4), keratin 5 (KRT5). Enrichment analysis with Reactome and Kegg databases highlighted the possible involvement of platelet release, glycolysis and HDL mediated lipid transport pathways. Moreover, string analysis revealed that HIF-1α (Hypoxia-inducible factor 1-alpha), one of the interacting partners of HBx (Hepatitis B X protein), may play a role in the altered glycolytic response and oxidative stress observed in liver fibrosis. Conclusions: To our knowledge, this is the first protomic research that studies HBV infected fibrotic human liver tissues to investigate alterations in protein levels and affected pathways among different fibrotic stages. Observed changes in the glycolytic pathway caused by HBx presence and therefore its interactions with HIF-1α can be a target pathway for novel therapeutic purposes.
Anahtar Kelimeler
Chronic hepatitis B | Glycolysis | Liver fibrosis | Proteomics | Two-dimensional difference gel electrophoresis